4//SEC Filing
GLASSMAN DANIEL 4
Accession 0000864268-05-000003
CIK 0000864268other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 12:09 PM ET
Size
17.1 KB
Accession
0000864268-05-000003
Insider Transaction Report
Form 4
GLASSMAN DANIEL
DirectorChairman, Pres. & CEO10% Owner
Transactions
- Discretionary Transaction
Common Stock
2005-01-14$15.27/sh+15$229→ 11,065 total(indirect: By 401(k))
Holdings
- 13,880(indirect: By Spouse)
Common Stock
- 18,000
Stock Options (Right to buy)
Exercise: $1.41From: 2001-09-12Exp: 2005-09-11→ Common Stock (18,000 underlying) - 341,589
Stock Options (Right to buy)
Exercise: $1.44From: 2000-12-05Exp: 2005-12-04→ Common Stock (341,589 underlying) - 9,733(indirect: By Partnership)
Class B Common Stock
- 8,460(indirect: By DLD Partners)
Common Stock
- 11,500(indirect: By IRA)
Common Stock
- 14,000(indirect: By Foundation)
Common Stock
- 57,370(indirect: By Spouse)
Class B Common Stock
- 12,554
Stock Options (Right to buy)
Exercise: $10.58From: 2003-07-09Exp: 2006-07-08→ Common Stock (12,554 underlying) - 315,000
Stock Options (Right to buy)
Exercise: $13.13From: 2003-03-22Exp: 2007-03-21→ Common Stock (315,000 underlying) - 449,090
Common Stock
- 325,366
Class B Common Stock
- 3,030(indirect: By 401(k))
Common Stock
- 25,000
Stock Options (Right to buy)
Exercise: $2.17From: 2001-02-23Exp: 2006-02-22→ Common Stock (25,000 underlying)
Documents
Issuer
BRADLEY PHARMACEUTICALS INC
CIK 0000864268
Entity typeother
Related Parties
1- filerCIK 0000902023
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 12:09 PM ET
- Size
- 17.1 KB